Cargando…
Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
Autores principales: | Reznik, Sandra E., Tiwari, Amit K., Ashby, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392972/ https://www.ncbi.nlm.nih.gov/pubmed/35150477 http://dx.doi.org/10.17305/bjbms.2021.6901 |
Ejemplares similares
-
Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023) -
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022) -
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection
por: Moghimi, Narges, et al.
Publicado: (2021) -
Sofosbuvir: A Potential Treatment for Ebola
por: Reznik, Sandra E., et al.
Publicado: (2018) -
Potential Use of Sofosbuvir in the Prophylaxis for Rabies
por: Reznik, Sandra E., et al.
Publicado: (2020)